Conversion Labs Inc fka CVLB

[Happy Investor]

Thanks for your effort. ALL SHAREHOLDERS SHOULD NOW MIGRATE TO LFMD

[Humble bee]

Thank you for adding it. I have never managed a board. Are you able to add yourself as the moderator to this existing board and update it? If yes, it would keep the history and existing followers.

[toddski]

Hi everyone. I made a LFMD board if any of you are interested in posting.

[jefra1965]

Great. All Longs should do the same to level up the playing field a little bit.

I don't see limiting sell prices as a fair practice. This is exactly why they do that. To have access to shares to short. How come they are always involved in massive Short Attacks.

They should NOT be able to limit the stock holder of any sell limit they want. They can limit the time the order remains open but not the price.

I wonder if that's legal. How come they are the only ones doing that?

A 50% upside is nothing with smaller stocks specially with small floats.

It's all business as usual I guess.

[Humble bee]

"LifeMD to Host Fourth Quarter and Full Year 2020 Conference Call on Monday, March 29, 2021 at 4:30 p.m. ET Nasdaq:LFMD" https://www.globenewswire.com/news-release/2021/03/17/2194572/0/en/LifeMD-to-Host-Fourth-Quarter-and-Full-Year-2020-Conference-Call-on-Monday-March-29-2021-at-4-30-p-m-ET.html

[Happy Investor]

Read This Before Selling LifeMD, Inc. (NASDAQ:LFMD) Shares


More content below

LFMD
+8.10%
Simply Wall St
Mon, March 15, 2021, 3:40 AM


More content below

LFMD
+8.10%
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So shareholders might well want to know whether insiders have been buying or selling shares in LifeMD, Inc. (NASDAQ:LFMD).

What Is Insider Buying?
It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries require that the company discloses such transactions to the market.


Insider transactions are not the most important thing when it comes to long-term investing. But it is perfectly logical to keep tabs on what insiders are doing. For example, a Columbia University study found that 'insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers'.

See our latest analysis for LifeMD

The Last 12 Months Of Insider Transactions At LifeMD
In the last twelve months, the biggest single purchase by an insider was when Chief Operating Officer Brad Roberts bought US$103k worth of shares at a price of US$20.50 per share. That means that an insider was happy to buy shares at above the current price of US$18.14. It's very possible they regret the purchase, but it's more likely they are bullish about the company. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.

While LifeMD insiders bought shares during the last year, they didn't sell. They paid about US$10.97 on average. It is certainly positive to see that insiders have invested their own money in the company. But we must note that the investments were made at well below today's share price. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
insider-trading-volume
LifeMD is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

LifeMD Insiders Bought Stock Recently
Over the last quarter, LifeMD insiders have spent a meaningful amount on shares. Not only was there no selling that we can see, but they collectively bought US$203k worth of shares. This could be interpreted as suggesting a positive outlook.

Insider Ownership of LifeMD
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that LifeMD insiders own 20% of the company, worth about US$95m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The LifeMD Insider Transactions Indicate?
It is good to see recent purchasing. And the longer term insider transactions also give us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. When combined with notable insider ownership, these factors suggest LifeMD insiders are well aligned, and that they may think the share price is too low. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing.

[Happy Investor]

Put in sell order at $300 on my shares held at Etrade. Since Fidelity limits sale price to 150% of current price, I didn't execute sell order because I would not be happy to sell at $29. This stock could spike to that level in a day.

[jefra1965]

Since the float is small, this should help restrict the short's operating at full force..

[Humble bee]

Thank you for this advice. I set mine up like this before opening.

[Happy Investor]

Thanks

[toddski]

I set mine gtc at 500/share on td couple weeks ago. Fidelity has limits of 50 percent higher than last quoted price so no dice there.

[Happy Investor]

Good strategy. You keep the brokers from lending the shares and I suppose you would be happy if they sold at $275. I think I will do this. All L-T holders should.

[jefra1965]

You know that they could use your shares anyways. They have used mine before without me knowing. I just placed a sell order for ALL at $275.00 to lock them up.

I use Charles Scwab.

[Happy Investor]

You apparently o not understand short selling, so I will attempt to explain it to you one more time despite your obvious lack of intelligence and your desire to just be negative.
The recent pattern of daily trading has been for the price to rise in pre-market trading, an indication of demand, followed by a rise in price at the opening, followed by a series of small sales at the bid which is an attempt to drive the price back down or limit the rise. This is a graphic indication of short selling.

However, most recently the shorts have not been able to cause a decline in the price and so we are now trading at $18.25, the high for the day. The inability of the shorts to achieve their goals is due to several factors--1) some of the short sellers have covered and moved on in the face of strengthening demand, 2) with more than 35% of the float sild short, it is increasingly difficult for short sellers to borrow shares to sell short. I was recently contacted by 2 brokerage firms where I hold substantial shares of LFMD to see if I would like to earn interest income on my holdings by lending shares. (of course I declined).

We may see a short squeeze develop soon as remaining shorts scurry to buy shares to cover their naked position.
An analogy may help you understand. Short sellers sell assets they do not possess and must later cover the sale. So, by analogy, if you sold brain matter you would be a short seller.

[Humble bee]

https://ir.lifemd.com/press-release-details.php#/?newsId=2189398

[pmunch]

15$ still .... was 30$ . Shorts weather ??

[xrymd]

Louis Silver: I told you my results on CVLB stock sales on an open message board just to rub your large nose in it. I can see from your spittle filled reply it has worked. LOL

FYI Mark never sold his stock position to Justin. He had over 10 million shares pre reverse split ( over 2 million post reverse split).

Louis you can do the math but you and I both know (at least I know) He made an absolute killing. I'm pretty sure that will definitely bother you.

[pmunch]

Oh my gosh LOL ...

[Happy Investor]

More absurd B.S. You lied constantly back when McLaughlin was CEO and the company was called IMMD. You lied about his performance as I daily slammed him for his incompetence and self-dealing until he finally threw in the towel and sold most of his position to Justin.

Who in their right mind would disclose what you just disclosed on a public board? Answer: only someone who is so low on self esteem that he has to bloviate and hyperbolize. Such a person would likely be a radiologist who lacks personality and self esteem to such an extent that he can't relate to actual patients but must settle for reviewing the output of Xray technicians and submitting reports to real physicians. technicians.

What a loser you are!

[Happy Investor]

Thanks Coach. I do not want the responsibility of leading a board.

[coach11]

Happy, Thanks for your constant updates as you see things progress. No reason to banter with other posters. Just keep sharing updates with us. Why don’t you start a new board, LFMD, I think new investors would find your post helpful and don’t think of searching the CVLB board.

[xrymd]

Louis Silver: I cant ever remember about a lie I told on I hub. Please point out a specific post I made. I mean what would be the point? All I know is that I made 8 figures on the stock with 80% residing in a Roth IRA. Louis can you say Ka-ching???

By the time of this last run (Mar 2020) I was down to 3.5 million shares (pre reverse split)

Lane

[Happy Investor]

Anyone can say anything they want on Ihub without verification. I followed IMMD at the time very closely, as you well know, and you never had that much. You have lied before on Ihub and you are lying now.

[Happy Investor]

LFMD closed at $15.96 then hit $17.00 AFTER hours.

Will the short squeeze begin on Monday?

[xrymd]

Louis Silver (Happy Investor) At one point pre reverse I owned 5 million shares and got into a dispute with TD Ameritrade (2017) as they accused me of owning more than 10% of IMMD. There were 35 million shares outstanding at that time but I countered TD Ameritrade that with unexercised options there were over 50 million shares outstanding. I lost the fight and they sent me packing to a new broker.

[Happy Investor]

NO sdo I say. Read my analysis in previous 2 posts.
information from published sources. You are an ignoramus and an idiot who makes sleazy remarks with no foundation instead of doing DD.
you should go back to watching your reality T V shows.

[pmunch]

It’s always the short sellers ... so they say

[Happy Investor]

The persistence of the short sellers belies their concern. They are still at it but when word spreads of LFMD's great execution they will get caught in a squeeze.. They will be covering as quickly as they can.

[Happy Investor]

Do you try very hard to post ridiculous statements?

Anyone who cannot see the short selling or does not understand it should put his money in money market.

[pmunch]

We were at 30$ as CVLB now 15$ as LFMD

Let me know when we rise back to baseline

[Happy Investor]

ACCELERATING REVENUE GROWTH OF 295%!!!!! SUBSCRIPTION REVEUE NOW AT 80% OF TOTAL!!!! CONSIERGE TELEMEDICINE AND NAVA MD VERY SOON!!!! JUST SCRATCHING THE SURFACE OF GROWTH OPPORTUNITIES!!!!!

LifeMD Q1 2021 Revenues on Track to Exceed $17 Million, up 295%, with Subscriptions Representing More than 80% of Total Revenue

NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD) (formerly Conversion Labs), a leading direct-to-patient telehealth company, expects revenue for the first quarter ending March 31, 2021 to exceed $17 million, up more than 295% compared to the same year-ago quarter.

“Given the strengthening sales and customer growth we’ve been seeing over the last few months, we are well on track for another record-breaking quarter that will once again exceed all expectations,” stated LifeMD CEO, Justin Schreiber. “We are now hitting an annualized run-rate of more than $68 million, with increasing momentum coming into March. Our growing recurring revenue stream from subscriptions is also providing us greater visibility into future performance.”

Subscriptions are expected to generate more than 80% of revenue in the quarter, compared to about 63% in the same year-ago period. The increase in subscription revenue is expected to be largely due to sales of the company’s Shapiro MD™ hair products for men and women under a new subscription-based program, as well as continued record subscription sales of the company’s telemedicine brand for men, Rex MD™.

“We believe this performance reflects our ability to deliver an expanding portfolio of telemedicine products and services to a growing population of patients across the U.S.,” commented LifeMD COO, Brad Roberts. “Over the course of the past year we established a strong foundation to address this opportunity and support rapid growth.”

Now just a few weeks away, the upcoming official launch of the company’s new subscription-based primary care and concierge telehealth services represents another valuable avenue for transforming the healthcare experience and attracting new patients to the LifeMD digital health platform.

“This new service is about realizing our vision for radically changing healthcare, by making the best physicians and medications more accessible and affordable,” added Schreiber. “From discreetly treating sexual health issues and hair loss, to providing long-term concierge care, we believe we will be able to dramatically improve the health and wellbeing of countless Americans.”

Anticipated as another major growth driver for 2021, the company will soon launch Nava MD™, a teledermatology clinic for women. Nava MD will offer teledermatology services and a clinically proven OTC technology to patients across all 50 states.

“As remarkable as our growth and market expansion has been over the last year, we believe we’ve only just begun to scratch the surface of our potential and market opportunity,” commented LifeMD CFO, Marc Benathen. “Our recently announced and completed $14 million strategic private placement supports our aggressive growth initiatives, including further scaling the size and reach of our digital health ecosystem, expanding our suite of brands for men’s and women’s health, and accelerating customer acquisition for our new concierge telehealth services.”

[Happy Investor]

As of now short interest is at least 25% of float!

[Happy Investor]

I watch the trading daily by minute. The charts indicate substantial short selling patterns for the last 7 or 8 trading days. In researching short interest I found the following:

1)As of 2/22 short selling as a % of volume was 3.2%
2) This rose steadily to 19% on 2/25 and settled to 13% moving forward through yesterday.
3) In general short interest has risen since Dec.
4) As of 2/12 (the last published data) short interest was 420,000 shares
5) Estimating short interest additions since 2/12 through yesterday using average daily volume and an average short sales as a % of volume of 15%, an additional 1.2mm shares have been shorted.
6) This brings total probable short interest to 1.6mm shares, which is 20% of estimated float. Pretty high but certainly not in the GME stratosphere. So we may see more short selling in the next several days, but shares are going to become scarce for borrowing and then shorts will attempt to cover.

If a significant announcement comes out that may drive up their prices.

We know Justin has significant institutional contacts. What is he waiting for? Get on the horn!!!

[pmunch]

What happened to the price ? Sunk

[jefra1965]

Thanks for the confirmation.

[Happy Investor]

From what I hear this is all accurate. Business is super. The short sellers, who are active this a.m., will be slain.

[jefra1965]

$LFMD. From another board

I called the company and it appears this quarter continues the strong growth! It even appears that the second derivative of growth is increasing which means that the growth rate itself is increasing. The contribution margin which is the company’s gross margin less variable costs continues to increase dramatically as the mix shifts to subscription based sales and more prescription sales from Rex. The company is launching many new and highly profitable products over the next 3 weeks. In addition this Conceirge launch which differentiates the company from all telemedicine companies and puts it in a class of its own has not been valued in the stock. This company is in its own growth cycle and should not be traded like the other telemed cos. They are growing faster and with independent sales dynamics. Plus they will be spinning out or selling a non strategic division with over $25/ shr by itself!

[Happy Investor]

Agree TDOC was way over valued and paid far too much. They will languish for quite a while.

LFMD is way undervalued based on its growth rate, infrastructure improvements and new products and services. \

I spoke to a trader who is substantial AND leads a substantial group of traders on Saturday. He was unaware of LFMD although he has been following telemedicine industry. We spent about 45 minutes on the phone, looking at LFMD charts, press releases, website, etc. He loves it! Feels that the 50% (of the run up) retracement was inevitable and sees strong support at this current level. He said he intended to move into LFMD on Monday.

[jefra1965]

That was just a big opportunity to go short, make money or increase the position. Either way is just temporary and a side effect of the broad market correction. This will pass.

The curious thing is that the whole TeleHealth sector went into a heavy correction. TDOC was very overpriced at $275-$308 a couple of weeks ago with P/S valuations close to 40X. Investors did not take into consideration that the share count almost doubled with the LVGO merger. The Gross margin will need time to improve and they are only expecting an 80% YoY growth which is very good for a company it's size but every valuation measure needs adjustment due to the increase in share count. The performance will be better but it's because there are 2 companies operating under the same roof.

It's a very interesting merger study case for those who have the time to learn about mergers and their effects in stock price action.

To me, the stock price will drop further to $175.00 because it is still overvalued at $220.00

IMO, the main reason is the huge price that TDOC payed for LVGO and too much expectation. The price was $18.5B, 66X TTM sales and 36X 2021E sales. I can understand why they did it but at the same time investors should have known that this will cause the stock price to move sideways for 12 to 18 months due to the dilution at such high LVGO valuation.

With an 80% estimated YoY growth rate for 2021 (maybe 60-65% for 2022) and a 63% FY2020 (Improving) gross margin I can not see TDOC holding it's current valuation for long. It's stock price will go lower. JMHO. I am interested in owning TDOC eventually and was expecting a sideways SP move for a while but had not had the chance to see all the real numbers before the last financial report.

LFMD is very undervalued at the moment but I am wondering how much of what's happening with TDOC will affect our stock in the short term. i'll be keeping track as it's very interesting to watch how this unfolds. The price drop @ TDOC did not recover before the close yesterday so I think that my theory could be right.

[Happy Investor]

Cigna's Evernorth to acquire telehealth company MDLive.

The article states that MDLive brought in $174 mm in funding since 2009.
Justin etal achieved the same thing with far less funding and in far less time!

Is something like this in LFMD's future? $200/sh?

[Happy Investor]

Thank you. I feel blessed.

What do you think about the short selling? Probably not surprising after the huge runup, but very risky in view of the growth and execution.